Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis

PLoS Medicine

Volumn 2, Issue 9, 2005, Pages 0891-0903

  Pardo, Annie ^a   Gibson, Kevin ^b   Cisneros, José ^c   Richards, Thomas J ^b   Yang, Yinke ^b   Becerril, Carina ^c   Yousem, Samueal ^d   Herrera, Iliana ^a   Ruiz, Victor ^c   Selman, Moisés ^c   Kaminski, Naftali ^b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; HERMES ANTIGEN; INTEGRIN; INTERSTITIAL COLLAGENASE; MATRILYSIN; OLIGONUCLEOTIDE; OSTEOPONTIN; PENTAPEPTIDE; MMP7 PROTEIN, HUMAN; RECOMBINANT PROTEIN; SIALOGLYCOPROTEIN; SPP1 PROTEIN, HUMAN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; DOWN REGULATION; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROBLAST; LUNG FIBROSIS; MALE; PROTEIN EXPRESSION; STATISTICAL MODEL; TISSUE MICROARRAY; UPREGULATION; CELL CULTURE; CELL MOTION; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GENETICS; LUNG; LUNG LAVAGE; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; PATHOLOGY;

BRONCHOALVEOLAR LAVAGE FLUID; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; EPITHELIAL CELLS; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LUNG; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 7; MIDDLE AGED; MOLECULAR SEQUENCE DATA; OSTEOPONTIN; PULMONARY FIBROSIS; RECOMBINANT PROTEINS; SIALOGLYCOPROTEINS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; UP-REGULATION;

EID: 25644460419     PISSN: 15491277     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pmed.0020251     Document Type: Article

References (50)

1. Selman M, King TE, Pardo A (2001) Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 134: 136-151.
2. Gross TJ, Hunninghake GW (2001) Idiopathic pulmonary fibrosis. N Engl J Med 345: 517-525.
3. Collard HR, King TE Jr. (2001) Treatment of idiopathic pulmonary fibrosis: The rise and fall of corticosteroids. Am J Med 110: 326-328.
4. Katzenstein AL, Myers JL (1998) Idiopathic pulmonary fibrosis: Clinical relevance of pathologic classi.cation. Am J Respir Crit Care Med 157: 1301-1315.
5. Crystal RG, Bitterman PB, Mossman B, Schwarz MI, Sheppard D, et al. (2002) Future research directions in idiopathic pulmonary fibrosis: Summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med 166: 236-246.
6. American Thoracic Society (2000) American Thoracic Society. Idiopathic pulmonary fibrosis: Diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161: 646-664.
7. ATS/ERS International Multidisciplinary Consensus Classi.cation of the Idiopathic Interstitial Pneumonias (2002) ATS/ERS International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the ATS and the ERS was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 165: 277-304.
8. O'Regan AW, Nau GJ, Chupp GL, Berman JS (2000) Osteopontin (Eta-1) in cell-mediated immunity: Teaching an old dog new tricks. Immunol Today 21: 475-478.
9. Reinholt FP, Hultenby K, Oldberg A, Heinegard D (1990) Osteopontin-A possible anchor of osteoclasts to bone. Proc Natl Acad Sci U S A 87: 4473-4475.
10. Weber GF, Ashkar S, Glimcher MJ, Cantor H (1996) Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271: 509-512.
11. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS (2001) Osteopontin as a means to cope with environmental insults: Regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 107: 1055-1061.
12. O'Regan A, Berman JS (2000) Osteopontin: A key cytokine in cell-mediated and granulomatous inflammation. Int J Exp Pathol 81: 373-390.
13. Kaminski N, Allard JD, Pittet JF, Zuo F, Griffiths MJ, et al. (2000) Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc Natl Acad Sci U S A 97: 1778-1783.
14. Zuo F, Kaminski N, Eugui E, Allard J, Yakhini Z, et al. (2002) Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc Natl Acad Sci U S A 99: 6292-6297.
15. Takahashi F, Takahashi K, Okazaki T, Maeda K, Ienaga H, et al. (2001) Role of osteopontin in the pathogenesis of bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 24: 264-271.
16. Berman JS, Serlin D, Li X, Whitley G, Hayes J, et al. (2004) Altered bleomycin-induced lung fibrosis in osteopontin-deficient mice. Am J Physiol Lung Cell Mol Physiol 286: L1311-1318.
17. Koguchi Y, Kawakami K, Uezu K, Fukushima K, Kon S, et al. (2003) High plasma osteopontin level and its relationship with interleukin-12-mediated type 1 T helper cell response in tuberculosis. Am J Respir Crit Care Med. 1355-1359.
18. Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, et al. (2000) Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity. Science 287: 860-864.
19. Kaminski N, Friedman N (2002) Practical approaches to analyzing results of microarray experiments. Am J Respir Cell Mol Biol 27: 125-132.
20. Reichert TE, Scheuer C, Day R, Wagner W, Whiteside TL (2001) The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma. Cancer 91: 2136-2147.
21. Richards TJ, Chensny LJ, Loutaev I, Fernando HC, Gibson KF, et al. (2004) Weakest link models for microarray data in idiopathic pulmonary fibrosis. Am J Resp Crit Care Med 169: A776.
22. Ramos C, Montano M, Garcia-Alvarez J, Ruiz V, Uhal BD, et al. (2001) Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression. Am J Respir Cell Mol Biol 24: 591-598.
23. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc B57: 289-300.
24. Persy VP, Verhulst A, Ysebaert DK, De Greef KE, De Broe ME (2003) Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knockout mice. Kidney Int 63: 543-553.
25. Trueblood NA, Xie Z, Communal C, Sam F, Ngoy S, et al. (2001) Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin. Circ Res 88: 1080-1087.
26. Matsui Y, Jia N, Okamoto H, Kon S, Onozuka H, et al. (2004) Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy. Hypertension 43: 1195-1201.
27. O'Regan AW, Chupp GL, Lowry JA, Goetschkes M, Mulligan N, et al. (1999) Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro. J Immunol 162: 1024-1031.
28. Carlson I, Tognazzi K, Manseau EJ, Dvorak HF, Brown LF (1997) Osteopontin is strongly expressed by histiocytes in granulomas of diverse etiology. Lab Invest 77: 103-108.
29. Gao YA, Agnihotri R, Vary CP, Liaw L (2004) Expression and characterization of recombinant osteopontin peptides representing matrix metalloproteinase proteolytic fragments. Matrix Biol 23: 457-466.
30. Philip S, Kundu GC (2003) Osteopontin induces nuclear factor kappa Bmediated promatrix metalloproteinase-2 activation through I kappa B alpha /IKK signaling pathways, and curcumin (diferulolylmethane) downregulates these pathways. J Biol Chem 278: 14487-14497.
31. Agnihotri R, Crawford HC, Haro H, Matrisian LM, Havrda MC, et al. (2001) Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin). J Biol Chem 276: 28261-28267.
32. Brabletz T, Jung A, Dag S, Hlubek F, Kirchner T (1999) Beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 155: 1033-1038.
33. El-Tanani M, Platt-Higgins A, Rudland PS, Campbell FC (2004) Ets gene PEA3 cooperates with beta-catenin-Lef-1 and c-Jun in regulation of osteopontin transcription. J Biol Chem 279: 20794-20806.
34. Chilosi M, Poletti V, Zamo A, Lestani M, Montagna L, et al. (2003) Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis. Am J Pathol 162: 1495-1502.
35. Xie Z, Singh M, Siwik DA, Joyner WL, Singh K (2003) Osteopontin inhibits interleukin-1beta-stimulated increases in matrix metalloproteinase activity in adult rat cardiac fibroblasts: Role of protein kinase C-zeta. J Biol Chem 278: 48546-48552.
36. Selman M, Ruiz V, Cabrera S, Segura L, Ramirez R, et al. (2000) TIMP-1,-2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? Am J Physiol Lung Cell Mol Physiol 279: L562-574.
37. Kolb M, Bonniaud P, Galt T, Sime PJ, Kelly MM, et al. (2002) Differences in the fibrogenic response after transfer of active transforming growth factorbeta1 gene to lungs of "fibrosis-prone" and "fibrosis- resistant" mouse strains. Am J Respir Cell Mol Biol 27: 141-150.
38. Ashizawa N, Graf K, Do YS, Nunohiro T, Giachelli CM, et al. (1996) Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction. J Clin Invest 98: 2218-2227.
39. Gadeau AP, Campan M, Millet D, Candresse T, Desgranges C (1993) Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in vitro. Arterioscler Thromb 13: 120-125.
40. Panda D, Kundu GC, Lee BI, Peri A, Fohl D, et al. (1997) Potential roles of osteopontin and alphaVbeta3 integrin in the development of coronary artery restenosis after angioplasty. Proc Natl Acad Sci U S A 94: 9308-9313.
41. O'Regan A (2003) The role of osteopontin in lung disease. Cytokine Growth Factor Rev 14: 479-488.
42. Sodek J, Zhu B, Huynh MH, Brown TJ, Ringuette M (2002) Novel functions of the matricellular proteins osteopontin and osteonectin/SPARC. Connect Tissue Res 43: 308-319.
43. Ponta H, Sherman L, Herrlich PA (2003) CD44: From adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 4: 33-45.
44. Kasper M, Bierhaus A, Whyte A, Binns RM, Schuh D, et al. (1996) Expression of CD44 isoforms during bleomycin-or radiation-induced pulmonary fibrosis in rats and mini-pigs. Histochem Cell Biol 105: 221-230.
45. Svee K, White J, Vaillant P, Jessurun J, Roongta U, et al. (1996) Acute lung injury fibroblast migration and invasion of a fibrin matrix is mediated by CD44. J Clin Invest 98: 1713-1727.
46. Teder P, Vandivier RW, Jiang D, Liang J, Cohn L, et al. (2002) Resolution of lung inflammation by CD44. Science 296: 155-158.
47. Sheppard D (2003) Functions of pulmonary epithelial integrins: From development to disease. Physiol Rev 83: 673-686.
48. Eliceiri BP, Cheresh DA (1999) The role of alphav integrins during angiogenesis: Insights into potential mechanisms of action and clinical development. J Clin Invest 103: 1227-1230.
49. Isacke CM, Yarwood H (2002) The hyaluronan receptor, CD44. Int J Biochem Cell Biol 34: 718-721.
50. Zhu B, Suzuki K, Goldberg HA, Rittling SR, Denhardt DT, et al. (2004) Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: Evidence of a role for an intracellular form of osteopontin. J Cell Physiol 198: 155-167.